首页 > 抗体蛋白 > 抗体
Purified anti-mouse VEGFR-3 (FLT-4) Antibody
产品名称:
Purified anti-mouse VEGFR-3 (FLT-4) Antibody
产品类别:
抗体
产品编号:
140901
产品应用:
140901
[价格]
规格 价格 库存
50µg ¥ 996 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
VEGFR-3-Fc fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

WB - Quality tested
Block, ELISA, IP, IHC-F - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by Western blotting. For Western blotting, the suggested use of this reagent is 1.0 ?g per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: ELISA1,2, immunoprecipitation1and Western blot1,2 from cell lysates, immunohistochemical staining1, 3 of frozen and paraffin embedded tissue sections and in whole-mount mouse embryos, in vivo blocking1, 5 of VEGF-C binding to inhibit angiogenesis, lymphangiogenesis, growth and metastasis of different tumor cells, in vitro blocking4 of VEGF-C binding to induce dispersion of endothelial cell clusters.

This clone detect multiple bands by western blot: a ~140 kD band corresponding to cleaved/soluble VEGFR-3, and 220 and 230 kD bands corresponding to unglycosylated and glycosylated full length VEGFR-3 (Bando, et al. 2004. Int J Canc. 111:184.)

Additional Product Notes

This product has been reported by a collaborator to work for immunohistochemical staining of frozen tissue sections.

Application References

(PubMed link indicates BioLegend citation)
  1. Kubo H, et al. 2000. Blood 96:546. (IP, WB, IHC, ELISA, Block)
  2. Zhang L, et al. 2010. Cell. Res. Epub ahead of print (WB, ELISA)
  3. Tammela T, et al. 2010. Nature 454:656. (IHC)
  4. Shimizu K, et al. 2004. Cancer Sci. 95:328. (Block)
  5. Matsumura K, et al. 2003. Blood 101:1367. (Block)
  6. Lee J, et al. 2012. PNAS 109:19638. PubMed
  7. Ozasa R, et al. 2012. J Exp Clin Cancer Res. 31:83. PubMed
Product Citations
  1. Ozasa R, et al. 2012. J Exp Clin Cancer Res. 31:83. PubMed
  2. Bieniasz–Krzywiec P, et al. 2020. Cell Metabolism. 30(5):917-936. PubMed
  3. Inverso D, et al. 2021. Developmental Cell. 56(11):1677-1693.e10. PubMed
  4. Lee J, et al. 2012. Proc Natl Acad Sci U S A. 109:19638. PubMed
RRID
AB_10683463 (BioLegend Cat. No. 140901) AB_10680790 (BioLegend Cat. No. 140902)

Antigen Details

Structure
Member of Tyr protein kinase family. Extracellular portion contains 7 immunoglobulin-like domains. Ligand binding is mediated by its domains 2 and 3. Cytoplasmic portion contains 1 protein kinase domain.
Distribution

Expressed on vascular endothelial cells during fetal development, constitutively expressed on lymphatic endothelium in adult mice, induced in tumors with active angiogenesis.

Function
Regulates angiogenesis and lymphangiogenesis.
Interaction
Associated with VEGFR-2 in the surface.
Ligand/Receptor
VEGF-C and D
Cell Type
Endothelial cells
Biology Area
Angiogenesis, Cell Biology, Immunology, Signal Transduction
Molecular Family
Cytokine/Chemokine Receptors, Protein Kinases/Phosphatase
Antigen References

1. Uhrin P, et al. 2010. Blood 115:3997.
2. Wang Y, et al. 2010. Nature 465:483.
3. Akobsson L, et al. 2009. Biochem. Soc. T. 37:1233.
4. Tammela T, et al. 2010. Nature 454:656.
5. Huang G and Chen L. 2008. Cancer Biother. Radio. 23:661.
6. Zhang YJ and Fang JY. 2008. J. Gastroen. Hepatol. 23:856.

Gene ID
14257 View all products for this Gene ID
UniProt
View information about VEGFR-3 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线